# Anterra Capital

> Anterra Capital is a VC fund in Amsterdam backing Biotechnology and AgTech. See 57 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Amsterdam, The Netherlands
- Total investments: 57
- Last investment: Mar 2026
- Lead investor: 39%
- Fund size: $260M
- Last fund: Jun 2021
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/3264301
- X (Twitter): https://twitter.com/anterracapital
- Website: http://www.anterracapital.com/

Anterra Capital is an independent growth capital fund. They invest in fast growing companies that are working to make the global food supply chain safer, more efficient and more sustainable. Their focus is on supporting the growth of companies who are commercializing novel technologies and services. They invest across the food supply chain fromnovel agro inputs and precision farming through to smarter logistics and consumer safety. They do not invest in other funds, land, operating assets, or other capital intensive businesses.They are a lead investor taking significant minority equity positions and performing an active role on the boards of the companies they support. At the time they invest, their companies typically already generate revenue and have great growth prospects. They target investments of EUR 1M to EUR 15M per company and often support their portfolio companies in raising additional capital from professional investors including from their own financial partners. Importantly, they are long-term investors. They focus on working closely with management teams to build lasting value.

## Contacts

5 contacts available for Anterra Capital. Shizune tracks 8 team members at Anterra Capital. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/anterra-capital?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $3M–$10M |
| Series A | $3.3M–$26M |
| Series B | $8.3M–$46M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 11 | 19% |
| AgTech | 5 | 9% |
| Agriculture | 5 | 9% |
| Software | 4 | 7% |
| Food and Beverage | 4 | 7% |

42 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 14 | 25% |
| Series A | 11 | 19% |
| Seed | 5 | 9% |
| Series C | 4 | 7% |
| Funding Round | 4 | 7% |

9 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 17 | 30% |
| United Kingdom | 4 | 7% |
| France | 2 | 4% |
| India | 1 | 2% |
| Germany | 1 | 2% |

7 countries tracked in total.

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Adam Anders | Managing Partner | 2 | https://shizune.co/investors/profile/adam-anders-2 |
| Brett Chevalier | Venture Partner | 0 | https://shizune.co/investors/profile/brett-chevalier |
| Brett Wong | Principal | 0 | https://shizune.co/investors/profile/brett-wong |
| Maarten Goossens | Principal | 0 | https://shizune.co/investors/profile/maarten-goossens |
| Philip Austin | Founding Partner | 6 | https://shizune.co/investors/profile/philip-austin-2 |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Anchr | Anchr develops an AI platform for automating knowledge work and workflow execution. The software connects to business data sources, ingests documents, and structures information for retrieval via chat interfaces and APIs. Core capabilities include document parsing, semantic search, agent-style task orchestration, and integrations with third‑partytools. Typical use cases include research synthesis, content drafting, customer support assistance, and internal reporting. The offering targets teams seeking to unify unstructured content and trigger actions from natural‑language prompts while retaining control over data and access. | $5.8M | Pre-Seed | Mar 10, 2026 |  |
| Berkeley Yeast | Berkeley Yeast engineers yeast strains to help brewers create beers that are delicious and sustainable. The company was founded by Berkeley PhDs in 2017. Its headquarters is based in Oakland, California. They consume around the world, from regional specialties to staples used by billions of people daily. This includes beer and wine, but also bread,cheese, vinegar, soy sauce, fish sauce, kombucha, miso, chocolate, and others. The list is long and reveals a broad and exciting horizon. |  | Series A | Dec 23, 2025 |  |
| Animol Discovery | Animol is building its own pipeline of break-through proprietary veterinary small molecules led by a team of animal health industry experts with vast experience in bringing drugs to market. With our unique and powerful technology platform we deliver innovative medicines that are specifically designed for the needs of veterinary patients. | $12M | Series C | Oct 17, 2025 |  |
| AgrigateOne | AgrigateOne is an online platform that enables openness between growers and buyers and gets data about agriculture and marine logistics. | $7.2M | Seed | Aug 08, 2025 |  |
| BiomEdit | BiomEdit is an innovation company that discovers, designs, and develops novel probiotics, microbiome derived bioactives, and engineered microbial medicines to address unmet needs in animal health. Our ambition is to create solutions to some of the most important problems in animal agriculture and food security by leveraging the potential of themicrobiome. BiomEdit’s technology is based on a unique platform that utilizes high-throughput sequencing and data analytics to rapidly discover and screen novel probiotic species and bioactive molecules. These can then be engineered to confer thermostability, enhanced production of beneficial metabolites, or expression of immune modulating proteins. These probiotics and microbially-derived compounds represent the next generation of products designed to promote animal health without the use of antibiotics. | $18.4M | Series B | Jul 15, 2025 |  |
| Dalma | Dalma offers transparent, subscription-based health insurance that covers pets, reimbursing costs related to illnesses, injuries, and preventive care. | $21.8M | Series B | Mar 17, 2025 |  |
| Dalma | Dalma offers transparent, subscription-based health insurance that covers pets, reimbursing costs related to illnesses, injuries, and preventive care. | $13M | Series B | Dec 20, 2024 |  |
| Animol Discovery | Animol is building its own pipeline of break-through proprietary veterinary small molecules led by a team of animal health industry experts with vast experience in bringing drugs to market. With our unique and powerful technology platform we deliver innovative medicines that are specifically designed for the needs of veterinary patients. | $9.5M | Series C | Nov 15, 2024 |  |
| Edge Animal Health | Animal Health | $11M | Series B | Jun 17, 2024 |  |
| Bonito Biosciences | Bonito Biosciences is a biotechnology research firm specializing in tissue-selective drug delivery for oligonucleotides and macromolecules. | $9M | Seed | May 31, 2024 |  |

10 of 57 investments shown.

## Co-investors
- [Finistere Ventures](https://shizune.co/investors/profile/finistere-ventures) — VC Fund, 9 deals together
- [Novalis LifeSciences](https://shizune.co/investors/profile/novalis-lifesciences) — VC Fund, 6 deals together
- [Eight Roads Ventures](https://shizune.co/investors/profile/eight-roads-ventures) — VC Fund, 5 deals together
- [Cavallo Ventures](https://shizune.co/investors/profile/cavallo-ventures) — VC Fund, 4 deals together
- [Endeavor8](https://shizune.co/investors/profile/endeavor8) — VC Fund, 4 deals together
- [Northpond Ventures](https://shizune.co/investors/profile/northpond-ventures) — VC Fund, 4 deals together

## Similar investors

### Similar industry
- [SVG Ventures](https://shizune.co/investors/profile/svg-ventures) — VC Fund
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Omnivore](https://shizune.co/investors/profile/omnivore-partners) — VC Fund

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

### Similar country
- [Titan Capital](https://shizune.co/investors/profile/titan-capital) — VC Fund
- [Inflection Point Ventures](https://shizune.co/investors/profile/inflection-point-ventures-d275) — VC Fund
- [Blume Ventures](https://shizune.co/investors/profile/blume-ventures) — VC Fund

## Featured in investor lists
- [Food and Beverage Investors in United Kingdom](https://shizune.co/investors/food-and-beverage-investors-united-kingdom)
- [Food and Beverage VC Funds in United Kingdom](https://shizune.co/investors/food-and-beverage-vc-funds-united-kingdom)
- [Gaming VC Funds in United Kingdom](https://shizune.co/investors/gaming-vc-funds-united-kingdom)
- [Gaming Investors in United Kingdom](https://shizune.co/investors/gaming-investors-united-kingdom)
- [Agriculture (agtech) Investors in United Kingdom](https://shizune.co/investors/agriculture-agtech-investors-united-kingdom)
- [Agriculture (agtech) VC Funds in United Kingdom](https://shizune.co/investors/agriculture-agtech-vc-funds-united-kingdom)

## FAQ

### What does Anterra Capital invest in?

Anterra Capital invests primarily in Biotechnology, AgTech and Agriculture startups, most often at Series B and Series A stage. Most of the 57 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Anterra Capital's check size?

Anterra Capital typically joins rounds of $3M–$10M at Seed, $3.3M–$26M at Series A and $8.3M–$46M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Anterra Capital participates in.

### How do I contact Anterra Capital?

Public channels for Anterra Capital include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Anterra Capital?

The team at Anterra Capital includes Adam Anders (Managing Partner), Brett Chevalier (Venture Partner) and Brett Wong (Principal), among 8 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co